3 Stocks Dragging In The Financial Sector

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 29 points (-0.2%) at 16,877 as of Thursday, June 19, 2014, 1:00 PM ET. The NYSE advances/declines ratio sits at 1,663 issues advancing vs. 1,297 declining with 187 unchanged.

The Financial sector currently is unchanged today versus the S&P 500, which is down 0.1%. On the negative front, top decliners within the sector include UBS ( UBS), down 1.6%, Credit Suisse Group ( CS), down 1.5%, CME Group ( CME), down 1.4%, Brookfield Asset Management ( BAM), down 1.1% and Aegon ( AEG), down 0.9%. Top gainers within the sector include Orix ( IX), up 3.3%, Ventas ( VTR), up 2.2%, Mitsubishi UFJ Financial Group ( MTU), up 1.8%, Deutsche Bank ( DB), up 1.1% and Nomura Holdings ( NMR), up 1.0%.

TheStreet would like to highlight 3 stocks pushing the sector lower today:

3. Prudential Financial ( PRU) is one of the companies pushing the Financial sector lower today. As of noon trading, Prudential Financial is down $0.95 (-1.1%) to $89.57 on light volume. Thus far, 803,189 shares of Prudential Financial exchanged hands as compared to its average daily volume of 2.7 million shares. The stock has ranged in price between $89.14-$90.52 after having opened the day at $90.52 as compared to the previous trading day's close of $90.52.

Prudential Financial, Inc. provides insurance, investment management, and other financial products and services to individual and institutional customers in the United States and internationally. Prudential Financial has a market cap of $41.1 billion and is part of the insurance industry. Shares are down 1.8% year-to-date as of the close of trading on Wednesday. Currently there are 11 analysts that rate Prudential Financial a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Prudential Financial as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, compelling growth in net income, good cash flow from operations, solid stock price performance and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Prudential Financial Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, American Express ( AXP) is down $0.76 (-0.8%) to $94.80 on average volume. Thus far, 1.6 million shares of American Express exchanged hands as compared to its average daily volume of 3.4 million shares. The stock has ranged in price between $94.53-$95.70 after having opened the day at $95.46 as compared to the previous trading day's close of $95.56.

American Express Company, together with its subsidiaries, provides charge and credit payment card products and travel-related services to consumers and businesses worldwide. The company operates through four segments: U.S. American Express has a market cap of $100.2 billion and is part of the financial services industry. Shares are up 5.3% year-to-date as of the close of trading on Wednesday. Currently there are 11 analysts that rate American Express a buy, 2 analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates American Express as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, impressive record of earnings per share growth, increase in net income and solid stock price performance. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full American Express Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Citigroup ( C) is down $0.50 (-1.0%) to $47.43 on average volume. Thus far, 8.2 million shares of Citigroup exchanged hands as compared to its average daily volume of 21.5 million shares. The stock has ranged in price between $47.34-$47.97 after having opened the day at $47.95 as compared to the previous trading day's close of $47.93.

Citigroup Inc., a diversified financial services holding company, provides various financial products and services to consumers, corporations, governments, and institutions. Citigroup has a market cap of $145.2 billion and is part of the banking industry. Shares are down 8.0% year-to-date as of the close of trading on Wednesday. Currently there are 15 analysts that rate Citigroup a buy, 1 analyst rates it a sell, and 5 rate it a hold.

TheStreet Ratings rates Citigroup as a buy. The company's strengths can be seen in multiple areas, such as its attractive valuation levels, expanding profit margins, increase in net income and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Citigroup Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the financial sector could consider Financial Select Sector SPDR ( XLF) while those bearish on the financial sector could consider Proshares Short Financials ( SEF).

null

More from Markets

Dow Skids and Stocks Fall Hard as Earnings Disappoint, Caterpillar Tumbles

Dow Skids and Stocks Fall Hard as Earnings Disappoint, Caterpillar Tumbles

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug

Video: Jim Cramer on Rising Interest Rates, Trade Worries & Caterpillar

Video: Jim Cramer on Rising Interest Rates, Trade Worries & Caterpillar